Amyloid Beta Peptides Inhibit Glucose Transport at the Blood-brain Barrier by Disrupting Insulin-Akt Pathway in Alzheimer's Disease
L. Wang, G. L. Curran, P. H. Min, L. Li, V. J. Lowe, K. K. Kandimalla
This study shows that amyloid-beta peptides inhibit glucose transport at the blood-brain barrier by disrupting the insulin-Akt pathway and increasing TXNIP expression.
bioRxiv · Nov 21, 2022 · PreprintPharmacology & Toxicology